Boehringer launches digital platform to raise awareness abou...

Boehringer Ingelheim and Carebox Healthcare Solutions have launched a digital platform aimed at giving patients, families, caregivers and doctors the opportunity to learn ab

Boehringer bags CHMP backing for Ofev in rare lung disease

Lilly, Boehringer bag FDA okay for diabetes triple Trijardy ...

BI buys rights to NASH-targeted tech from Singapore's Enleof...

Boehringer Ingelheim has bought rights to preclinical technology aimed at fibro-inflammatory diseases including the fatty liver disease known as NASH, a prime target for many pharma compani

Boehringer cleared to manufacture BeiGene's cancer drug for ...

Boehringer Ingelheim is to manufacture the first biologic drug approved in China using a new regulatory system, designed to strengthen the country’s domestic pharma infrastructure.

Boehringer, Lilly start acute heart failure trial with Jardi...